Why the study?
What are the clinical predictors for the lack of favorable vascular response to statin therapy in patients with coronary artery disease?
What are the clinical predictors for the lack of favorable vascular response to statin therapy in patients with coronary artery disease?
In patients with coronary artery disease, chronic kidney disease predicts a poor vascular response to statin therapy, whereas presenting with acute coronary syndrome predicts a favorable response.
Answers are grounded in this paper and cite their sources.
CKD may warrant alternative lipid strategies in CAD; leaves open causal mechanisms and trial confirmation of differential responses.
BACKGROUND: Previous studies have demonstrated that statin therapy improves cardiac outcomes, probably by stabilizing thin-cap fibroatheroma in patients with coronary artery disease. However, major adverse cardiac events still occur in some patients, despite statin therapy. The aim of this study is to identify clinical predictors for the lack of a favorable vascular response to statin therapy in patients with coronary artery disease. METHODS AND CONCLUSIONS: Chronic kidney disease is an independent predictor for the lack of a favorable vascular response to statin therapy, whereas acute coronary syndrome is an independent predictor for favorable vascular response to statin therapy. These findings should be further warranted in future prospective studies. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01110538.
No takes yet. Share an insight, caveat, or question.
Minami et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: